Form 4: Relay Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Donald A. Bergstrom, President of R&D at Relay Therapeutics, sold 648 shares of common stock to cover income tax withholding obligations upon the vesting of restricted stock units.
Summary
- On September 27, 2024, Donald A. Bergstrom, President of R&D at Relay Therapeutics, sold 648 shares of common stock.
- The sale was executed at a price of $7.51 per share.
- The transaction was to cover income tax withholding obligations related to the vesting of 2,188 restricted stock units (RSUs) on September 26, 2024.
- Following the transaction, Bergstrom directly owns 523,433 shares of Relay Therapeutics, which includes 459,049 shares underlying RSUs.
Sentiment
Score: 5
Explanation: This is a routine transaction to cover tax obligations, so it's neutral in sentiment. It doesn't indicate any particular positive or negative outlook for the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders (officers, directors, or those holding more than 10% of the company's shares) buy or sell the company's securities. This filing indicates a routine transaction to cover tax obligations related to vested RSUs, which is a common practice among executives.
Key Dates
| Date | Description |
|---|---|
| 09/26/2024 | Vesting date of 2,188 shares of restricted stock units (RSUs). |
| 09/27/2024 | Date of the stock sale transaction. |
| 10/01/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.